Advertisement

Indications for Reoperative Parathyroidectomy

  • Michael C. SingerEmail author
Chapter

Abstract

Surgery for primary hyperparathyroidism will successfully cure the vast majority of patients. However, a small number of patients will experience persistent or recurrent disease after their primary parathyroidectomy. Selecting which of these patients should undergo reoperative surgery is challenging. While the indications to proceed with surgery may be present, proceeding with surgery requires careful consideration of multiple patient and disease characteristics that impact the likelihood of success. Critically, without reliable localization information directing the surgeon, reoperation should only be conducted in patients with severe sequelae of their disease.

Keywords

Indications for surgery Preoperative planning Decision-making Reoperative parathyroidectomy 

References

  1. 1.
    Giddings CE, Rimmer J, Weir N. History of parathyroid gland surgery: a historical case series. J Laryngol Otol. 2009;123:1075–81.CrossRefPubMedGoogle Scholar
  2. 2.
    Allendorf J, DiGorgi M, Spanknebel K, et al. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80.CrossRefPubMedGoogle Scholar
  3. 3.
    Clark OH. Symposium: parathyroid disease – part 1. Contemp Surg. 1998;52:137–52.Google Scholar
  4. 4.
    Jaskowiak N, Norton JA, Alexander HR, et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg. 1996;224:308–20.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Shen W, Duren M, Morita E, et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg. 1996;131:861–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Prescott JD, Udelsman R. Remedial operation for primary hyperparathyroidism. World J Surg. 2009;22:2324–34.CrossRefGoogle Scholar
  7. 7.
    Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96:2950–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Oltman SC, Maalouf NM, Holt S. Significance of elevated parathyroid hormone after parathyroidectomy for primary hyperparathyroidism. Endocr Pract. 2011;17(suppl 1):57–62.CrossRefGoogle Scholar
  9. 9.
    Carty SE, Roberts MM, Virji MA, et al. Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery. 2002;132:1086–92.CrossRefPubMedGoogle Scholar
  10. 10.
    Ning L, Sippel R, Schaeger S, et al. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism. Ann Surg. 2009;249:469–72.CrossRefPubMedGoogle Scholar
  11. 11.
    Westerdahl J, Valdemarsson S, Lindblom P, et al. Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption. World J Surg. 2000;24:1323–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Beyer TD, Solorzano CC, Prinz RA, et al. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery. 2007;141:777–83.CrossRefPubMedGoogle Scholar
  13. 13.
    Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014;99:3580–94.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    National Institutes of Health. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus development conference. Consens Stat. 1990;8:1–18.Google Scholar
  15. 15.
    Bilezikian JP, Potts JT Jr, Fuleihan G-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Wells SA, Debenedetti MK, Doherty GM. Recurrent or persistent hyperparathyroidism. J Bone Miner Res. 2002;17:N158–62.PubMedGoogle Scholar
  19. 19.
    Udelsman R, Donovan PI. Remedial parathyroid surgery. Ann Surg. 2006;244:471–9.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Doherty GM, Weber B, Norton JA. Cost of unsuccessful surgery for primary hyperparathyroidism. Surgery. 1994;116:954–7.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Otolaryngology – Head and Neck Surgery, Division of Thyroid and Parathyroid SurgeryHenry Ford Health SystemDetroitUSA

Personalised recommendations